Within the tumor immune microenvironment (TIME), tumor cells can aberrantly express ligands that engage immune checkpoint receptors (such as PD - 1, CTLA - 4, and LAG - 3) on T cells, thereby restricting immune activity and promoting immune evasion. Here, RPL17 is linked to neoplasm.